Correlation Between Mangoceuticals, Common and FOXO Technologies

Can any of the company-specific risk be diversified away by investing in both Mangoceuticals, Common and FOXO Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangoceuticals, Common and FOXO Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mangoceuticals, Common Stock and FOXO Technologies, you can compare the effects of market volatilities on Mangoceuticals, Common and FOXO Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangoceuticals, Common with a short position of FOXO Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangoceuticals, Common and FOXO Technologies.

Diversification Opportunities for Mangoceuticals, Common and FOXO Technologies

-0.54

Correlation Coefficient

Mangoceuticals, Common  FOXO Technologies

Excellent diversification

The 3 months correlation between Mangoceuticals, and FOXO is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Mangoceuticals, Common Stock and FOXO Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FOXO Technologies and Mangoceuticals, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangoceuticals, Common Stock are associated (or correlated) with FOXO Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FOXO Technologies has no effect on the direction of Mangoceuticals, Common i.e., Mangoceuticals, Common and FOXO Technologies go up and down completely randomly.

Pair Corralation between Mangoceuticals, Common and FOXO Technologies

Given the investment horizon of 90 days Mangoceuticals, Common Stock is expected to generate 0.52 times more return on investment than FOXO Technologies. However, Mangoceuticals, Common Stock is 1.92 times less risky than FOXO Technologies. It trades about 0.18 of its potential returns per unit of risk. FOXO Technologies is currently generating about -0.1 per unit of risk. If you would invest  250.00  in Mangoceuticals, Common Stock on November 29, 2024 and sell it today you would earn a total of  189.00  from holding Mangoceuticals, Common Stock or generate 75.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.33%
Values	Daily Returns

Mangoceuticals, Common Stock  vs.  FOXO Technologies

Mangoceuticals, Common

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mangoceuticals, Common Stock are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Mangoceuticals, Common showed solid returns over the last few months and may actually be approaching a breakup point.

FOXO Technologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days FOXO Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Mangoceuticals, Common and FOXO Technologies

The main advantage of trading using opposite Mangoceuticals, Common and FOXO Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangoceuticals, Common position performs unexpectedly, FOXO Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FOXO Technologies will offset losses from the drop in FOXO Technologies' long position.

The idea behind Mangoceuticals, Common Stock and FOXO Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.